Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ganglioneuroblastoma 3Breast Neoplasms 3Neuroblastoma 2Gliosarcoma 2Glioblastoma 2Wilms Tumor 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Thoracic Diseases 1Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Seroma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pancreatic Neoplasms 1Ovarian Germ Cell Cancer 1Neoplasm Metastasis 1Lymphatic Metastasis 1Lung Neoplasms 1

Interventions

nilutamide 1luprolide acetate gel depot 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Salicylic Acid 1Radiation 1PROSTVAC 1Leuprolide 1Goserelin 1Flutamide 1Docetaxel 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Stage I Prostate Adenocarcinoma AJCC v7 × Congresses as Topic × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡